No Detail Found!

Frequency of myocarditis in COVID-19 patients

Author(s)
Shams Ul Islam Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Dur-e-Zahra Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Muhammad Shabbir Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Sajid Khan Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Muhammad Najeeb Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Aleena Khan Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Zeenat Shaheen Khyber Teaching Hopital Peshawar, Pakistan
Fazal Amin Civil Hospital, Jamrud Khyber Agency, Peshawar, Pakistan
Muhammad Bilal Siddique Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Abdul Hameed Siddiqui Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Abstract
Objective: To determine frequency of myocarditis in COVID-19 patients. Study Design: Cross-sectional study. Place and Duration of Study: Armed Forces Institute of Cardiology-National Institute of Heart Diseases (AFIC-NIHD), Rawalpindi and Pak Emirates Military Hospital (PEMH), Rawalpindi, from Dec 2020 to May 2021. Methodology: A total of 143 hospitalized patients who had tested positive for COVID-19 infection via RT-PCR were included in the study. Patients with pre-existing cardiac conditions were excluded. All patients underwent transthoracic echocardiography and their ejection fractions were recorded. Meticulous testing for the inflammatory markers including CRP, serum ferritin, procalcitonin and interleukin-6 (IL-6) and cardiac biomarker (NT-pro-BNP) was carried out. The data was recorded on a specially designed questionnaire and later transferred to SPSS-23 for analysis. Myocarditis was diagnosed on the basis of reduced Ejection Fraction or raised NT pro BNP or both in a person without any known cardiac pathologies before getting COVID-19. Results: Out of total 143 COVID-19 patients included in the study, 24 patients (16.8%) developed myocarditis. The frequency of myocarditis in COVID-19 positive male population was 14.6% (10.5% of all myocarditis cases) and that of female population was 22.5% (6.3% of all myocarditis cases). The raised pro-inflammatory markers IL-6 and CRP were significantly associated with development of myocarditis while ferritin was not significantly associated. Only 28% of the study population recovered and got discharged from the hospital, however, there were no survivors among those who developed myocarditis. Conclusion: Myocarditis is a serious complication of COVID-19 and directly linked to increased mortality risk. There is an increasing need to perform serial assays for the inflammatory as well as cardiac biomarkers including IL-6, Trop-I and NTpro-BNP for early detection and prompt treatment of this not so uncommon complication.
Publication Details
Page(s) 349-352
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 71, Issue: S2, Year: 2021

Request the full text from PASTIC

Keywords
echocardiography, COVID-19, IL-6, Myocarditis, Transthoracic., NT-pro-BNP
0

Citations

0

Downloads

62

Views